8 results match your criteria: "Cleveland Clinic in Ohio[Affiliation]"

Serious Mental Illness and Its Impact on Diabetes Care in a VA Nurse/ Pharmacist-Managed Population.

Fed Pract

October 2017

is a primary care clinical pharmacy specialist at the Cleveland Clinic in Ohio. is a primary care clinical pharmacy specialist; is the PGY-2 ambulatory care pharmacy residency program director and a primary care clinical pharmacy specialist; is a board-certified clinical health psychologist in primary care; is a certified diabetes educator; provides statistical support in the Geriatric Research Education and Clinical Center; and is a primary care clinical pharmacy specialist, all at the Louis Stokes Cleveland VAMC in Ohio. Dr. Burant is an associate professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland. Dr. Pascuzzi, and Dr. Leciejewski are preceptors for the PGY-1 and 2 pharmacy residency programs, and Dr. Milkovich completed her PGY-2 ambulatory care pharmacy residency at the Louis Stokes Cleveland VAMC.

Collaboration between a registered nurse-certified diabetes educator and clinical pharmacy specialist improved access to care and glycemic control in veterans with diabetes and mental illness.

View Article and Find Full Text PDF

Background: A seven-item cancer-specific fall risk tool (Cleveland Clinic Capone-Albert [CC-CA] Fall Risk Score) was shown to have a strong concordance index for predicting falls; however, validation of the model is needed.

Objectives: The aims of this study were to validate that the CC-CA Fall Risk Score, made up of six factors, predicts falls in patients with cancer and to determine if the CC-CA Fall Risk Score performs better than the Morse Fall Tool.

Methods: Using a prospective, comparative methodology, data were collected from electronic health records of patients hospitalized for cancer care in four hospitals.

View Article and Find Full Text PDF

Patient fears are an ever-present factor of patient care, and addressing those fears is a responsibility of the healthcare provider. One such fear may be of tumor cell dissemination secondary to surgical interventions. Preparing for such discussions will allow the healthcare provider to speak with authority on the topic of tumor dissemination secondary to breast biopsy or surgery, even in a situation where a patient has underlying fears.

View Article and Find Full Text PDF

Kidney dysfunction is a common clinical feature of symptomatic multiple myeloma. Some degree of renal insufficiency or renal failure is present at diagnosis or will occur during the course of the disease and, if not reversed, will adversely affect overall survival and quality of life. Chronic insults to the kidneys from other illnesses, treatment, or multiple myeloma itself can further damage renal function and increase the risk for additional complications, such as anemia.

View Article and Find Full Text PDF